Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Xilio Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
3
| Frankenfield Christopher James (COO) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 04/03/2023 |
3
| Brennan Kevin M. (SVP, FINANCE AND ACCOUNTING) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 11/16/2022 |
3
| English Edward C (Principal Accounting Officer) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 09/16/2022 |
3
| Heyman Tomas J. (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 06/17/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/06/2022 |
3
| Xu Yuan (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 11/05/2021 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/22/2021 |
3
| Williams John Charles (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Flynn James E (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| FIL Ltd (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Alexandria Venture Investments, LLC (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Estate of Ulrich Rodeck (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| CLACKSON TIMOTHY P (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| TOMLINSON SIMON M (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Rock Springs Capital Management LP (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Merck KGaA (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| FMR LLC (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Atlas Venture Fund XI, L.P. (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Ross Michael Jay (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Curran Daniel J. (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Russo Rene (CEO and President) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Bonstein Sara (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Giovine Salvatore (CFO) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Clancy Paul J (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| HUMPHREY RACHEL (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| RiverVest Venture Fund IV, L.P. (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| TAKEDA PHARMACEUTICAL CO LTD (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Huber Martin H. Jr. (President of R&D and CMO) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| SV7 Impact Medicine Fund LP (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| LYNCH DANIEL (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/21/2021 |
3
| Rossi Christina (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
|
|